Radiology Department, University of Eastern Piedmont, "Maggiore della Carità" Hospital, Corso Mazzini 18, 28100, Novara, Italy.
Medical Physics Department, University of Eastern Piedmont, "Maggiore della Carità" Hospital, Novara, Italy.
Radiol Med. 2016 Jul;121(7):537-45. doi: 10.1007/s11547-016-0626-5. Epub 2016 Mar 31.
The aim of this study was to compare the accuracy of retrospective image fusion of PET/MRI-DWI with that of PET/CT and MRI-DWI alone in detecting metastatic lymph nodes in patients with cervical and endometrial carcinoma.
Twenty-seven patients with endometrial (n = 14) and cervical (n = 13) cancer who had undergone preoperative MRI-DWI and PET/CT for staging were retrospectively evaluated. The accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of PET/CT, MRI-DWI, and PET/MRI-DWI image fusion were calculated on a per-patient basis and on a per-node basis. Histopathological and follow-up imaging results were used as the gold standard.
On a per-patient basis PET/MRI-DWI had the same sensitivity (87.5 %), specificity (84.2 %), diagnostic accuracy (85.1 %), PPV (70 %), and NPV (94.1 %) as PET-CT, but on a per-node basis PET/MRI-DWI showed better sensitivity (89 vs 70.2 %), specificity (91.6 vs 90.5 %), diagnostic accuracy (91.2 vs 87 %), PPV (68.7 vs 60.4 %), and NPV (97.6 vs 93.6 %) than PET-CT. Comparison of the areas under the ROC curves for the detection of metastatic lymph nodes demonstrated a non-significant difference (p = 0.055) between PET/CT and fused PET/MRI-DWI.
PET/MRI-DWI may be a valuable technique for N-staging patients with endometrial and cervical cancer, but more studies are needed to investigate its potential clinical utility.
本研究旨在比较 PET/MRI-DWI 后处理图像融合与单独 PET/CT 和 MRI-DWI 检测宫颈癌和子宫内膜癌患者转移性淋巴结的准确性。
回顾性分析 27 例经术前 MRI-DWI 和 PET/CT 分期的子宫内膜癌(n=14)和宫颈癌(n=13)患者。基于患者和淋巴结,计算 PET/CT、MRI-DWI 和 PET/MRI-DWI 图像融合的准确性、敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)。以组织病理学和随访影像学结果为金标准。
基于患者,PET/MRI-DWI 与 PET-CT 具有相同的敏感性(87.5%)、特异性(84.2%)、诊断准确性(85.1%)、PPV(70%)和 NPV(94.1%);但基于淋巴结,PET/MRI-DWI 显示出更好的敏感性(89% vs 70.2%)、特异性(91.6% vs 90.5%)、诊断准确性(91.2% vs 87%)、PPV(68.7% vs 60.4%)和 NPV(97.6% vs 93.6%)。转移性淋巴结检测的 ROC 曲线下面积比较显示,PET/CT 和融合 PET/MRI-DWI 之间无显著差异(p=0.055)。
PET/MRI-DWI 可能是一种有价值的技术,可用于检测子宫内膜癌和宫颈癌患者的 N 分期,但需要更多研究来探讨其潜在的临床应用价值。